Remaining gene copy performs work of two
A UCLA study demonstrated that enhancer-targeted CRISPR helps the remaining gene copy compensate for double workload in autism organoids. This proof-of-concept addresses haploinsufficiency in genetic susceptibility.
- Field
- gene therapy
- What they did
- Researchers from UCLA demonstrated that a CRISPR-based tool can fix the function of a remaining gene copy when one copy is hindered by a mutation, helping to model autism.
- Why it matters
- This could be useful for people with autism, as approximately 15% of genetic susceptibility to autism spectrum disorder is caused by such mutations, and fixing the gene could compensate for their deficiency.
#crispr#autism#haploinsufficiency#organoid#gene therapy



